Tivic Health Systems (NASDAQ:TIVC – Get Free Report) and electroCore (NASDAQ:ECOR – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, institutional ownership and profitability.
Analyst Ratings
This is a summary of recent ratings for Tivic Health Systems and electroCore, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Tivic Health Systems | 0 | 0 | 0 | 0 | N/A |
| electroCore | 0 | 0 | 1 | 0 | 3.00 |
Risk and Volatility
Profitability
This table compares Tivic Health Systems and electroCore’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Tivic Health Systems | -606.47% | -172.08% | -133.45% |
| electroCore | -66.84% | -165.17% | -78.53% |
Valuation & Earnings
This table compares Tivic Health Systems and electroCore”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Tivic Health Systems | $1.18 million | 1.29 | -$8.24 million | N/A | N/A |
| electroCore | $21.28 million | 2.02 | -$18.83 million | ($2.85) | -2.51 |
Tivic Health Systems has higher earnings, but lower revenue than electroCore.
Insider and Institutional Ownership
4.3% of Tivic Health Systems shares are owned by institutional investors. Comparatively, 26.7% of electroCore shares are owned by institutional investors. 0.4% of Tivic Health Systems shares are owned by company insiders. Comparatively, 13.1% of electroCore shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Summary
electroCore beats Tivic Health Systems on 8 of the 10 factors compared between the two stocks.
About Tivic Health Systems
Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
About electroCore
electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Receive News & Ratings for Tivic Health Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivic Health Systems and related companies with MarketBeat.com's FREE daily email newsletter.
